Bellevue Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.42K | Hold |
34
| – | – | ﹤0.01% | 314 |
|
|
2025
Q1 | $7.18K | Buy |
34
+1
| +3% | +$211 | ﹤0.01% | 297 |
|
|
2024
Q4 | $6.04K | Hold |
33
| – | – | ﹤0.01% | 324 |
|
|
2024
Q3 | $6.65K | Hold |
33
| – | – | ﹤0.01% | 292 |
|
|
2024
Q2 | $5.73K | Hold |
33
| – | – | ﹤0.01% | 305 |
|
|
2024
Q1 | $6.02K | Buy |
33
+1
| +3% | +$182 | ﹤0.01% | 292 |
|
|
2023
Q4 | $5.08K | Hold |
32
| – | – | ﹤0.01% | 303 |
|
|
2023
Q3 | $4.84K | Hold |
32
| – | – | ﹤0.01% | 294 |
|
|
2023
Q2 | $4.33K | Buy |
32
+1
| +3% | +$135 | ﹤0.01% | 322 |
|
|
2023
Q1 | $5.07K | Hold |
31
| – | – | ﹤0.01% | 314 |
|
|
2022
Q4 | $5.06K | Hold |
31
| – | – | ﹤0.01% | 311 |
|
|
2022
Q3 | $4K | Buy |
31
+1
| +3% | +$129 | ﹤0.01% | 319 |
|
|
2022
Q2 | $5K | Hold |
30
| – | – | ﹤0.01% | 318 |
|
|
2022
Q1 | $5K | Hold |
30
| – | – | ﹤0.01% | 348 |
|
|
2021
Q4 | $4K | Buy |
+30
| New | +$4K | ﹤0.01% | 393 |
|